(4S)-4-amino-4-[[(1S)-4-amino-1-carboxy-butyl]carbamoyl]butanoic acid
Modify Date: 2025-08-24 19:26:14
![(4S)-4-amino-4-[[(1S)-4-amino-1-carboxy-butyl]carbamoyl]butanoic acid Structure](https://image.chemsrc.com/caspic/364/56523-61-6.png)
(4S)-4-amino-4-[[(1S)-4-amino-1-carboxy-butyl]carbamoyl]butanoic acid structure
|
Common Name | (4S)-4-amino-4-[[(1S)-4-amino-1-carboxy-butyl]carbamoyl]butanoic acid | ||
|---|---|---|---|---|
| CAS Number | 56523-61-6 | Molecular Weight | 261.275 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 613.7±55.0 °C at 760 mmHg | |
| Molecular Formula | C10H19N3O5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 324.9±31.5 °C | |
Use of (4S)-4-amino-4-[[(1S)-4-amino-1-carboxy-butyl]carbamoyl]butanoic acidγ-Glutamylornithine is the urine excreta of patients with HHH syndrome (hyperuricemia, hyperaminemia, and hypercitrullinuria) and rotary atrophy associated with hyperuricemia. Increased levels of endogenous ornithine increase levels of γ-Glutamylornithine in the urine[1]. |
| Name | γ glutamyl ornithine |
|---|---|
| Synonym | More Synonyms |
| Description | γ-Glutamylornithine is the urine excreta of patients with HHH syndrome (hyperuricemia, hyperaminemia, and hypercitrullinuria) and rotary atrophy associated with hyperuricemia. Increased levels of endogenous ornithine increase levels of γ-Glutamylornithine in the urine[1]. |
|---|---|
| Related Catalog | |
| Target |
Human Endogenous Metabolite |
| References |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 613.7±55.0 °C at 760 mmHg |
| Molecular Formula | C10H19N3O5 |
| Molecular Weight | 261.275 |
| Flash Point | 324.9±31.5 °C |
| Exact Mass | 261.132477 |
| LogP | -1.55 |
| Vapour Pressure | 0.0±3.8 mmHg at 25°C |
| Index of Refraction | 1.544 |
| γ glutamyl ornithine |
| L-α-Glutamyl-L-ornithine |
| L-Ornithine, L-α-glutamyl- |